[HTML][HTML] End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - journals.lww.com
Rationale: Immune system deregulation, including AAV, is a key event that may potentially
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - ingentaconnect.com
Rationale: Immune system deregulation, including AAV, is a key event that may potentially
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 …
V Moronti, F Carubbi, L Sollima, L Piscitani… - Medicine, 2023 - pubmed.ncbi.nlm.nih.gov
Rationale Immune system deregulation, including AAV, is a key event that may potentially
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - europepmc.org
Rationale: Immune system deregulation, including AAV, is a key event that may potentially
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
[HTML][HTML] End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - journals.lww.com
Immune system deregulation, including AAV, is a key event that may potentially evolve into
ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA, particularly aHUS …
ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA, particularly aHUS …
[HTML][HTML] End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - ncbi.nlm.nih.gov
Rationale: Immune system deregulation, including AAV, is a key event that may potentially
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
evolve into ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA …
End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 …
V Moronti, F Carubbi, L Sollima, L Piscitani, C Ferri - Medicine, 2023 - europepmc.org
Immune system deregulation, including AAV, is a key event that may potentially evolve into
ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA, particularly aHUS …
ESRD. Abnormal activation of the cAP is also a cardinal feature of TMA, particularly aHUS …